West Pharma
Tech Group Europe, a medical device manufacturer based in Mulhuddart, Dublin, Ireland, serving the pharmaceutical and medical industries, is expanding its Dublin manufacturing and development centre. The expansion is the result of securing a significant programme with a leading global pharmaceutical partner. Tech Group Europe is a subsidiary of West Pharmaceutical Services, Inc., Exton, Pennsylvania, US.
The programme involves the manufacture, assembly and decoration of a complex injectable device for the diabetes market and will go into full-scale production in 2015. The device will be shipped to the customer’s European filling site for final assembly. The new programme will require the expansion of the existing Tech Group Dublin site by 1,115 m2.
Don O’Callaghan, Vice President and General Manager of Tech Group Europe, said, “This expansion reinforces the commitment to developing the Dublin capability as part of an ongoing long-term investment plan.
“This first phase in the expansion comes about as a result of an exciting win with a leading global pharmaceutical partner in the fast-growing diabetes market and further strengthens West’s position as one of the world’s leading manufacturers of complex medical devices for the pharmaceutical market.”
Tech Group Europe is focused on supplying engineering and manufacturing services for complex drug delivery devices and diagnostic solutions for the pharmaceutical and healthcare sectors. The facility was established in Ireland in 1998.
West works with the leading multi-national pharmaceutical companies with products that help facilitate safe insulin administration for patients around the world. The company manufactures components for insulin pens and glucose monitoring systems at facilities in Arizona, US. In addition, West manufactures plungers and lined seals for insulin pen cartridges from facilities in Denmark, Germany and the US.
West Pharmaceutical Services, Inc., +1 610 594 2900, west.pharmaceutical.services@westpharma.com, www.westpharma.com.